Ruthenium complexes containing bis-benzimidazole derivatives as a new class of apoptosis inducers.
about
Cytoxicity and apoptotic mechanism of ruthenium(II) amino acid complexes in sarcoma-180 tumor cellsSynthesis, relaxivity, and in vitro fluorescence imaging studies of a novel d-f heterometallic trinuclear complex as a potential bimodal imaging probe for MRI and optical imaging.Imidazole derivatives: a comprehensive survey of their recognition properties.Metallomics insights into the programmed cell death induced by metal-based anticancer compounds.Insights into the in vitro Anticancer Effects of Diruthenium-1.Topoisomerase IIα poisoning and DNA double-strand breaking by chiral ruthenium(ii) complexes containing 2-furanyl-imidazo[4,5-f][1,10]phenanthroline derivatives.A selenium-containing ruthenium complex as a cancer radiosensitizer, rational design and the important role of ROS-mediated signalling.Mixed-ligand ruthenium polypyridyl complexes as apoptosis inducers in cancer cells, the cellular translocation and the important role of ROS-mediated signaling.Mitochondrial fragmentation is an important cellular event induced by ruthenium(II) polypyridyl complexes in osteosarcoma cells.Mitochondria are the primary target in the induction of apoptosis by chiral ruthenium(II) polypyridyl complexes in cancer cells.The induction of mitochondria-mediated apoptosis in cancer cells by ruthenium(II) asymmetric complexes.Zinc(II) complexes containing bis-benzimidazole derivatives as a new class of apoptosis inducers that trigger DNA damage-mediated p53 phosphorylation in cancer cells.Ruthenium complexes containing 2,6-bis(benzimidazolyl)pyridine derivatives induce cancer cell apoptosis by triggering DNA damage-mediated p53 phosphorylation.The development of anticancer ruthenium(ii) complexes: from single molecule compounds to nanomaterials.Ruthenium(II) [3 + 2 + 1] mixed ligand complexes: substituent effect on photolability, photooxidation of bases, photocytotoxicity and photonuclease activity.In vitro and in vivo anti-proliferative evaluation of bis(4'-(4-tolyl)-2,2':6',2″-terpyridine)copper(II) complex against Ehrlich ascites carcinoma tumors.Highly stable selenadiazole derivatives induce bladder cancer cell apoptosis and inhibit cell migration and invasion through the activation of ROS-mediated signaling pathways.Rational Design of Ruthenium Complexes Containing 2,6-Bis(benzimidazolyl)pyridine Derivatives with Radiosensitization Activity by Enhancing p53 Activation.Ru(II)/diphenylphosphine/pyridine-6-thiolate complexes induce S-180 cell apoptosis through intrinsic mitochondrial pathway involving inhibition of Bcl-2 and p53/Bax activation.Enhancement of Antiangiogenic Efficacy of Iron(II) Complex by Selenium Substitution.Characterization of the Activities of Dinuclear Thiolato-Bridged Arene Ruthenium Complexes against Toxoplasma gondii.Antiangiogenic ruthenium(ii) benzimidazole complexes, structure-based activation of distinct signaling pathways.Aquation Is a Crucial Activation Step for Anticancer Action of Ruthenium(II) Polypyridyl Complexes to Trigger Cancer Cell Apoptosis.Novel ruthenium(II) polypyridyl complexes as G-quadruplex stabilisers and telomerase inhibitors.
P2860
Q28543888-65CD0CE5-3C3C-43BD-AE83-D4956404CA60Q35786129-745DAEF2-EE94-4DB3-9BDD-580BE19410D3Q37979120-4116A5DD-04CF-4334-9784-59517AAFD0F2Q38199383-96F81E9F-6830-4226-85F7-00683FBF14BBQ38750151-64C063AC-89E9-439F-A320-EC0E986BBF8AQ38768406-DECA5F58-EC3E-4BC8-93C7-29C18913AD88Q38921651-21BD1584-FBF4-44F1-BA34-A978D2320F40Q38969205-E6B42DC5-0DD2-4F39-BCBA-E1B6F0EE7F56Q39036280-BF09E8B0-D5A7-4D50-BAA0-F438C79DB65FQ39052398-F46F079C-9EB7-40DC-B544-68B3AFD29EE5Q39182036-73BEF9F5-0D0A-476D-B790-F7699958DDEEQ39184979-734AA454-FBA1-4038-BB95-2FB76346AB61Q39280971-00A0F1B4-6744-4192-A5F9-F09AE43EF59BQ39400527-9F660495-93B2-4015-ACB3-2CD9B20BF8D0Q42834264-33754FD2-472E-4B2C-BF51-29D21A15E90AQ46310417-302248C6-AB1A-4BF6-AA35-6A91234F391FQ46480998-275AF1ED-F392-4DD7-BD5F-C317DB168E1CQ46737262-09609066-F409-4A45-897B-723D4DD3099BQ47970194-2B62C1CA-B3E0-458B-907E-BF724D018B6EQ48822702-3894E3E0-AC98-43F7-AC2F-E11375C8C5BBQ50288394-3036895B-EB9F-41B4-A28B-9A56405D2EBAQ51013825-619F34E8-5FFB-40A2-9B6B-E8E90D955486Q53463488-18C190D5-16D4-49D4-9014-4579384F88F3Q53582568-0B75EB77-3E48-425A-8937-B51FC2FE61F5
P2860
Ruthenium complexes containing bis-benzimidazole derivatives as a new class of apoptosis inducers.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Ruthenium complexes containing ...... w class of apoptosis inducers.
@en
Ruthenium complexes containing ...... w class of apoptosis inducers.
@nl
type
label
Ruthenium complexes containing ...... w class of apoptosis inducers.
@en
Ruthenium complexes containing ...... w class of apoptosis inducers.
@nl
prefLabel
Ruthenium complexes containing ...... w class of apoptosis inducers.
@en
Ruthenium complexes containing ...... w class of apoptosis inducers.
@nl
P2093
P2860
P356
P1433
P1476
Ruthenium complexes containing ...... w class of apoptosis inducers.
@en
P2093
Cundong Fan
Tianfeng Chen
Wenjie Zheng
Yum-Shing Wong
P2860
P304
P356
10.1039/C1DT11950H
P407
P577
2011-12-09T00:00:00Z